Ergocalciferol | |
---|---|
(3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol |
|
Other names
Drisdol (Sanofi-Synthelabo), Calcidol (Patrin Pharma) |
|
Identifiers | |
CAS number | 50-14-6 |
PubChem | 5280793 |
ChemSpider | 4444351 |
UNII | VS041H42XC |
DrugBank | DB00153 |
KEGG | C05441 |
ChEBI | CHEBI:28934 |
ChEMBL | CHEMBL1536 |
Jmol-3D images | Image 1 |
|
|
|
|
Properties | |
Molecular formula | C28H44O |
Molar mass | 396.65 g/mol |
Melting point |
114–118 °C |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
Infobox references |
Ergocalciferol is a form of vitamin D, also called vitamin D2. It is marketed under various names including Deltalin (Eli Lilly and Company), Drisdol (Sanofi-Synthelabo) and Calcidol (Patrin Pharma). It is created from viosterol, which in turn is created when ultraviolet light activates ergosterol (which is found in fungi and named as a sterol from ergot) and so comes only from plants.
Ergocalciferol is widely used as a Vitamin D supplement, and a 2011 clinical guideline[1] considers it to be as effective as cholecalciferol (Vitamin D3), which is produced naturally by the skin when it is exposed to ultraviolet light. However there is now conflicting evidence regarding how similarly D2 and D3 behave in the body and whether they are equally potent. Some studies suggest D3 is more potent,[2][3] but others have found that they are equally effective.[4][5]
|
|